EFFICACY IN WEIGHT REDUCTION AND SAFETY IN PEDIATRIC AGE GROUPS WITH RARE MELANOCORTIN-4 RECEPTOR PATHWAYRELATED OBESITY TREATED WITH SETMELANOTIDE FOR 12 MONTHS